KROS R&D Expense Growth
Keros Therapeutics Inc · R&D Expense Growth
KROS R&D Expense Growth
Latest reported-25.33%period ending
KROS FY R&D Growth (YoY) (0.00% → -25.33%)
Latest values, visible window
High-resolution chart · PNG
KROS r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -25.3333% | |
| 28.3687% | |
| 54.9968% | |
| 58.2522% | |
| 62.8559% | |
| 94.8328% | |
| 71.8821% | |
| 0% |